Deep Health AI

Why is Deep Health AI India Ltd falling/rising?

As of 13-Aug, the stock price of Deep Health AI India Ltd is currently at 1.98, reflecting a downward trend with a year-to-date decline of -66.33%. The stock is trading below its moving averages and has seen reduced investor interest, despite a high dividend yield of 5.05%.

As of 13-Aug, the stock price of Deep Health AI India Ltd is falling, currently at 1.98, which reflects a change of -0.01 or -0.5%. The stock has been on a downward trend, having lost -1% over the last two days. This decline is further evidenced by its performance over various periods, where it has decreased by -3.88% over the past month and a significant -66.33% year-to-date, compared to a much smaller decline of -8.38% in the benchmark Sensex during the same timeframe.<BR><BR>Additionally, the stock is trading below its moving averages across multiple timeframes, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish trend. Investor participation has also diminished, with delivery volume dropping by -47.56% against the 5-day average, suggesting reduced interest in the stock. Despite a high dividend yield of 5.05%, these negative factors contribute to the overall decline in the stock's price.

Which are the latest news on Deep Health AI?

Who are in the management team of Deep Health AI?

The management team of Deep Health AI includes Ganpat Lal Nyati (Executive Director), Sonali Laddha (CEO), and several non-executive directors: Narendra Shrimali, Ashish Jain, and Vinod Mandowara, along with Company Secretary Prashant Tali and Additional Director Kaushal Jain.

The management team of Deep Health AI includes the following individuals:<BR><BR>1. Ganpat Lal Nyati - Executive Director & Wholetime Director<BR>2. Narendra Shrimali - Non-Executive & Non-Independent Director<BR>3. Ashish Jain - Non-Executive & Non-Independent Director<BR>4. Vinod Mandowara - Non-Executive & Non-Independent Director<BR>5. Prashant Tali - Company Secretary & Compliance Officer<BR>6. Sonali Laddha - Executive Director & CEO<BR>7. Kaushal Jain - Additional Director<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

What does Deep Health AI do?

Deep Health AI India Ltd manufactures and wholesales gold set jewellery with diamonds and provides consultancy services to the Pharmaceutical Industry. As of June 2026, it reported net sales of 0 Cr and a net profit of -2 Cr, with a market cap of INR 29 Cr.

Overview: <BR>Deep Health AI India Ltd operates in the Gems, Jewellery and Watches industry, focusing on the manufacture and wholesale of gold set jewellery with diamonds, as well as providing consultancy services to the Pharmaceutical Industry.<BR><BR>History: <BR>Deep Health AI India Ltd was established in 1994. The company has recently expanded its operations to include consultancy services for the Pharmaceutical Industry. The latest quarterly results reported are for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 0 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: -2 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 29 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 4.00 <BR>Industry P/E: 52 <BR>Dividend Yield: 5.05% <BR>Debt-Equity: -0.17 <BR>Return on Equity: 13.41% <BR>Price to Book: 0.56 <BR><BR>Contact Details: <BR>Address: 101 1st Floor Hemu Plaza, D J Road Vile Parle (W) Mumbai Maharashtra : 400056 <BR>Tel: 91-22-26174321/65043314 <BR>Website: http://www.deepdiamondindialimited.com

Are Deep Health AI India Ltd latest results good or bad?

Deep Health AI India Ltd's latest results are concerning, showing a net loss of ₹4.51 crores in Q4 FY26, a 1,388.57% decline year-on-year, and a revenue drop of 44.44%. The company faces significant operational and financial challenges, reflected in a 50.80% decline in stock value over the past year.

The latest results for Deep Health AI India Ltd are concerning and indicate a significant decline in performance. In the fourth quarter of FY26, the company reported a net loss of ₹4.51 crores, which is a staggering 1,388.57% decrease compared to the same quarter last year. This marks a drastic shift from profitability to substantial losses, highlighting severe operational challenges.<BR><BR>Revenue for the same quarter was only ₹0.25 crores, reflecting a 44.44% decline year-on-year and a 50% drop from the previous quarter. This revenue collapse suggests that the company is struggling to establish a sustainable business model, especially as it attempts to diversify into pharmaceutical consultancy services.<BR><BR>Additionally, the company's profit before tax was negative ₹5.54 crores, indicating significant one-off charges or exceptional items that have not been detailed. The operational metrics reveal a company in distress, with an operating margin of just 20% on minimal revenue, and a PAT margin of -1,804%.<BR><BR>The stock has also suffered severely, declining 50.80% over the past year, underperforming significantly compared to broader market indices. Given these factors, the overall assessment of Deep Health AI India Ltd's latest results is decidedly negative, suggesting that the company is facing critical operational and financial challenges.

When is the next results date for Deep Health AI India Ltd?

The next results date for Deep Health AI India Ltd is 13 August 2026.

The next results date for Deep Health AI India Ltd is scheduled for 13 August 2026.

How big is Deep Health AI?

As of 10th June, Deep Health AI India Ltd has a market capitalization of 30.00 Cr, with recent net sales of 4.25 Cr and net profit of 1.12 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Deep Health AI India Ltd has a market capitalization of 30.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4.25 Cr, while the sum of Net Profit for the same period is 1.12 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 22.36 Cr, and Total Assets amount to 23.96 Cr.

Who are the peers of the Deep Health AI?

Deep Health AI's peers include U. H. Zaveri, Manoj Jewellers, and several others, with varying management risks and growth rates. U. H. Zaveri has the highest 1-year return at 138.77%, while Deep Health AI has the lowest at -54.16%.

Peers: The peers of Deep Health AI are U. H. Zaveri, Sarup Industries, Manoj Jewellers, Shoora Designs, Kanani Industrie, Kenvi Jewels, Orosil Smiths, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel.<BR><BR>Quality Snapshot: Excellent management risk is observed at Manoj Jewellers, while Good management risk is found at Deep Health AI. Below Average management risk is noted at U. H. Zaveri, Shoora Designs, Kanani Industrie, Kenvi Jewels, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel, and the rest. Growth is Excellent at Manoj Jewellers, Good at Deep Health AI, and Below Average at U. H. Zaveri, Shoora Designs, Kanani Industrie, Kenvi Jewels, Orosil Smiths, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel, and the rest. Average capital structure is seen at Manoj Jewellers, Good at Deep Health AI, and Below Average at U. H. Zaveri, Shoora Designs, Kanani Industrie, Kenvi Jewels, Orosil Smiths, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is U. H. Zaveri at 138.77%, while the peer with the lowest is Deep Health AI at -54.16%. Deep Health AI's 1-year return is significantly lower than that of U. H. Zaveri. Additionally, peers with negative six-month returns include Deep Health AI, Kanani Industrie, Kenvi Jewels, Goenka Diamond, and Orosil Smiths.

Should I buy, sell or hold Deep Health AI India Ltd?

How has been the historical performance of Deep Diamond?

Deep Diamond has experienced a significant decline in net sales over three years, dropping from 7.67 Cr in Mar'23 to 1.26 Cr in Mar'25, while improving profitability metrics such as operating profit and profit before tax in the latest year. Total liabilities and assets increased slightly, and shareholder's funds strengthened, indicating a challenging environment with some recovery in profitability.

Answer:<BR>The historical performance of Deep Diamond shows a significant decline in net sales over the past three years, dropping from 7.67 Cr in Mar'23 to 2.56 Cr in Mar'24, and further down to 1.26 Cr in Mar'25. Total operating income followed a similar trend, decreasing from 7.67 Cr in Mar'23 to 2.56 Cr in Mar'24, and then to 1.26 Cr in Mar'25. Despite the decline in sales, the company managed to improve its operating profit (PBDIT) from 1.85 Cr in Mar'23 to 0.84 Cr in Mar'24, and further to 1.20 Cr in Mar'25. Profit before tax also increased from 1.73 Cr in Mar'23 to 0.57 Cr in Mar'24, reaching 1.09 Cr in Mar'25. The profit after tax showed a similar pattern, with values of 1.26 Cr, 0.42 Cr, and 0.86 Cr for the respective years. The earnings per share (EPS) decreased from 0.26 in Mar'23 to 0.08 in Mar'24, but increased to 0.17 in Mar'25. <BR><BR>In terms of balance sheet results, total liabilities rose slightly from 23.06 Cr in Mar'24 to 23.96 Cr in Mar'25, while total assets also increased from 23.06 Cr to 23.96 Cr in the same period. Shareholder's funds improved from 20.42 Cr in Mar'24 to 22.36 Cr in Mar'25, indicating a strengthening equity position. The cash flow from operating activities remained stagnant at 0.00 Cr in Mar'25, while it was negative at -5.00 Cr in Mar'24. The closing cash and cash equivalents remained unchanged at 3.00 Cr for both years. Overall, Deep Diamond's financial performance reflects a challenging environment with declining sales but some recovery in profitability metrics in the latest year.

Is Deep Diamond overvalued or undervalued?

As of May 30, 2025, Deep Diamond is considered very expensive and overvalued, with a PE ratio of 15.01, an EV to EBIT of 12.30, and a disappointing year-to-date return of -30.99%, especially compared to its peers and the Sensex's positive return of 5.61%.

As of 30 May 2025, the valuation grade for Deep Diamond has moved from risky to very expensive. This indicates a significant shift in the perception of the company's value, suggesting that it is currently overvalued. The key ratios reflect this sentiment, with a PE ratio of 15.01, an EV to EBIT of 12.30, and a ROE of 3.94%. <BR><BR>In comparison to its peers, Deep Diamond's valuation stands out unfavorably; for instance, Titan Company has a PE ratio of 94.61 and Kalyan Jewellers at 81.3, both indicating a more robust market position despite their higher valuations. The company's recent stock performance has also been underwhelming, with a year-to-date return of -30.99%, contrasting sharply with the Sensex's positive return of 5.61% over the same period. Overall, Deep Diamond appears to be overvalued in the current market context.

What is the technical trend for Deep Diamond?

As of June 5, 2025, Deep Diamond's trend is mildly bearish, with daily moving averages indicating a bearish outlook, while weekly indicators show mixed signals, leading to an overall weak trend.

As of 5 June 2025, the technical trend for Deep Diamond has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a mildly bearish outlook, while the weekly MACD shows a mildly bullish signal, contrasting with the monthly MACD which remains bearish. The Bollinger Bands are bearish on both weekly and monthly time frames, and the KST indicates a mildly bullish trend weekly but mildly bearish monthly. Overall, the lack of strong signals from the RSI and Dow Theory suggests a weak trend in both weekly and monthly perspectives.

Who are the top shareholders of the Deep Diamond?

The top shareholders of Deep Diamond are primarily individual investors, holding 89.27% of shares. Notable shareholders include Bhavishya Ecommerce Private Limited at 3.55%, and Prakash Rikhabchand Solanki, the main promoter, with 0.02%.

The top shareholders of Deep Diamond include individual investors, who hold a significant 89.27% of the shares. Among the notable public shareholders, Bhavishya Ecommerce Private Limited holds 3.55%. The promoter with the highest holding is Prakash Rikhabchand Solanki, with a stake of 0.02%. Additionally, there is one Foreign Institutional Investor (FII) that holds 1.04% of the shares. There are no pledged promoter holdings or mutual fund schemes involved in the shareholding structure.

Has Deep Diamond declared dividend?

No Dividend History Available